These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9204605)

  • 21. Development and small-scale production of a severely heated factor VIII concentrate.
    Knevelman A; de Wit HJ; Potstra P; vd Does JA
    Vox Sang; 1994; 66(2):89-95. PubMed ID: 8184598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue.
    Rock G; Neurath D; Lu M; Alharbi A; Freedman M
    Vox Sang; 2006 Oct; 91(3):252-5. PubMed ID: 16958838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-pool high-yield factor VIII production.
    Smit Sibinga CT
    Crit Rev Clin Lab Sci; 1986; 24(1):43-70. PubMed ID: 3098500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of heparin and calcium chloride on assay, stability, and recovery of factor VIII.
    Morgenthaler JJ; Zuber T; Friedli H
    Vox Sang; 1985; 48(1):8-17. PubMed ID: 3918394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma factor VIII, variables affecting stability under standard blood bank conditions and correlation with recovery in concentrates.
    Pepper MD; Learoyd PA; Rajah SM
    Transfusion; 1978; 18(6):756-60. PubMed ID: 726024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet collection during plasma exchange donation of cryoprecipitate.
    McLeod BC; Sassetti RJ; Cole ER; Scott JP
    Prog Clin Biol Res; 1990; 337():481-3. PubMed ID: 2112755
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative protein chemistry studies on Factor VIII concentrates].
    Kienast K; Trobisch H
    Arzneimittelforschung; 1984; 34(8):895-900. PubMed ID: 6437415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
    Geng Y; Wu CG; Bhattacharyya SP; Tan D; Guo ZP; Yu MY
    Transfusion; 2007 May; 47(5):883-9. PubMed ID: 17465954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processing.
    Farrugia A; Grasso S; Douglas S; Harrap R; Oates A; Young I; James J; Whyte G
    Transfusion; 1992 Oct; 32(8):755-9. PubMed ID: 1412684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Improved factor VIII yield in cryoprecipitate using a quick thaw technique.
    Davidson JF; McAdam JH; Mackenzie MJ; Kavanagh ML
    Thromb Diath Haemorrh; 1975 Nov; 34(2):590. PubMed ID: 1198502
    [No Abstract]   [Full Text] [Related]  

  • 33. Slow thaw siphon technique for cryoprecipitate production.
    Chudgar UH; Chandy M; Pulimood RB; Khanduri U
    Indian J Med Res; 1989 Aug; 90():295-9. PubMed ID: 2516011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modification of J.G. Pool's technic for the production of cryoprecipitates with highly concentrated antihemophilic globulin (factor 8) content. I].
    Wegner H; Bergmann A
    Z Gesamte Inn Med; 1967 Jul; 22(13):389-92. PubMed ID: 5592690
    [No Abstract]   [Full Text] [Related]  

  • 35. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Improvement of the preparation of factor VIII concentrates.
    Vermeer C; Soute BA; Brummelhuis HG
    Thromb Diath Haemorrh; 1975 Nov; 34(2):589-90. PubMed ID: 1198501
    [No Abstract]   [Full Text] [Related]  

  • 38. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human parvovirus PARV4 in clotting factor VIII concentrates.
    Fryer JF; Hubbard AR; Baylis SA
    Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freezing of plasma and recovery of factor VIII.
    Carlebjörk G; Blombäck M; Pihlstedt P
    Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.